What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database

Abstract Background Genetic testing plays an important role in guiding screening, diagnosis, and precision treatment of breast cancer (BC). However, the appropriate genetic testing criteria remain controversial. The current study aims to facilitate the development of suitable strategies by analyzing...

Full description

Bibliographic Details
Main Authors:	Mengqian Ni, Fang Wang, Anli Yang, Qiong Shao, Cong Xue, Wen Xia, Fei Xu, Xi Lin, Jiajia Huang, Xiwen Bi, Ruoxi Hong, Meiting Chen, Qiufan Zheng, Kuikui Jiang, Xinhua Xie, Jun Tang, Xi Wang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Xin An
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	Cancer Medicine
Subjects:	BRCA1/2 genes genetic testing criteria hereditary breast cancer multigene panel testing non‐BRCA genes pathogenic or likely pathogenic variants
Online Access:	https://doi.org/10.1002/cam4.5976

Similar Items

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer
by: Abdel-Razeq H, et al.
Published: (2023-01-01)

Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study
by: Omar Alejandro Zayas-Villanueva, et al.
Published: (2019-07-01)

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
by: Georgios N. Tsaousis, et al.
Published: (2019-06-01)

CÁNCER HEREDITARIO DE MAMA HEREDITARY BREAST CÁNCER
by: Sonia Margarit
Published: (2008-01-01)

Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort
by: Ahmed Bouras, et al.
Published: (2023-06-01)

Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
by: Jiayu Wang, et al.
Published: (2019-05-01)

BRCA1/2 Variants and Metabolic Factors: Results From a Cohort of Italian Female Carriers
by: Andreina Oliverio, et al.
Published: (2020-11-01)

BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort
by: Jiasheng Chian, et al.
Published: (2021-06-01)

BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis
by: Zhewen Feng, et al.
Published: (2023-08-01)

The Identification by Exome Sequencing of Candidate Genes in <i>BRCA</i>-Negative Tunisian Patients at a High Risk of Hereditary Breast/Ovarian Cancer
by: Dorra BenAyed-Guerfali, et al.
Published: (2022-07-01)

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history
by: Rozany Mucha Dufloth, et al.

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01)

Genetic Landscape of Male Breast Cancer
by: Fernando Augusto Batista Campos, et al.
Published: (2021-07-01)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
by: Xiaofei Wang, et al.
Published: (2022-08-01)

Breast Cancer; Clinical Spectrum and Genetic Abnormalities in Women of Reproductive Age-Retrospective Study.
by: Syed Muhammad Ali Haider, et al.
Published: (2023-12-01)

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
by: Mev Dominguez-Valentin, et al.
Published: (2018-01-01)

Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo‐ECAG) ovarian study
by: Hikmat Abdel‐Razeq, et al.
Published: (2023-04-01)

Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
by: Hosneara Akter, et al.
Published: (2019-09-01)

Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study
by: Felicia Adam, et al.
Published: (2023-01-01)

Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies
by: Angela Toss, et al.
Published: (2019-02-01)

The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada
by: Steven A. Narod, et al.
Published: (2021-04-01)

Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
by: Lauren C. Tindale, et al.
Published: (2022-06-01)

Prevalence of the <it>BRCA1 </it>founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald Ingrid P, et al.
Published: (2011-12-01)

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
by: Falk Zakrzewski, et al.
Published: (2019-04-01)

Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
by: Jeanna M. McCuaig, et al.
Published: (2022-04-01)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
by: Gianluca Tedaldi, et al.
Published: (2020-04-01)

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
by: Cecilie Heramb, et al.
Published: (2018-01-01)

Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer
by: Marcelo Moreno, et al.
Published: (2023-08-01)

Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer
by: Jean Pascal Demba Diop, et al.
Published: (2019-05-01)

Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
by: Reva Basho, et al.
Published: (2023-09-01)

Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis
by: Federico Anaclerio, et al.
Published: (2023-02-01)

Implicações éticas dos testes genéticos de suscetibilidade ao câncer de mama
by: Nedy Maria Branco Cerqueira Neves, et al.
Published: (2022-11-01)

Barriers and Facilitating Factors for Implementation of Genetic Services: A Public Health Perspective
by: Martina C. Cornel, et al.
Published: (2017-08-01)

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
by: Seth K. Rummel, et al.
Published: (2020-01-01)

Hereditary Breast Cancer in Romania—Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country
by: Andreea Cătană, et al.
Published: (2023-05-01)

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

Predicting the Pathogenic Potential of BRCA1 and BRCA2 Gene Variants Identified in Clinical Genetic Testing
by: Clare Brookes, et al.
Published: (2015-05-01)

Screening for Mutations in Hereditary Cancer Susceptibility Genes in a Region with High Endogamy in Brazil
by: Polyanna Oliveira, et al.
Published: (2023-12-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)